Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in NUVB — Nuvation Bio Inc.

CIK 1009207 New York, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,475,199
+$4,789,290 QoQ
Shares Held
1,140,000
+190.1% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 242 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. NUVB ranks #88 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 5,877,959 $626,707,987
2 ALNY
Alnylam Pharmaceuticals, Inc.
 1,104,109 $332,369,932
3 EXEL
Exelixis, Inc.
 5,551,747 $302,070,554
4 BBIO
BridgeBio Pharma, Inc.
 3,633,007 $270,586,360
5 TGTX
Tg Therapeutics, Inc.
 3,400,808 $186,840,390
6 HALO
Halozyme Therapeutics, Inc.
 2,006,479 $157,047,110
7 AXSM
Axsome Therapeutics, Inc.
 604,753 $148,025,391
8 PTCT
Ptc Therapeutics, Inc.
 1,548,919 $126,345,322

All Filings in NUVB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,475,199 1,140,000
2026-03-31 $1,685,909 392,986
2025-12-31 $7,847,185 875,802
2025-03-31 $21,296 12,100
2024-12-31 $126,084 47,400
2024-09-30 $254,709 111,227
2024-06-30 $501,641 171,795
2024-03-31 $3,133,821 860,940
2023-12-31 $777,543 514,930
2023-09-30 $91,080 67,971
2023-06-30 $202,024 112,236
2023-03-31 $132,303 79,701
2022-12-31 $227,080 118,271
2022-09-30 $490,168 218,825
2022-06-30 $478,596 147,715
2022-03-31 $172,412 32,778
2021-12-31 $594,745 69,970
2021-09-30 $1,644,980 165,491
2021-06-30 $1,572,598 168,915